Clinical Trials List
2020-10-15 - 2022-06-07
Phase III
Recruiting10
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳明恭 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HSI-CHUNG CHEN Division of Psychiatry
- HUNG-KUANG SU Division of Psychiatry
- Tzung-Jeng Hwang Division of Psychiatry
- YI-TING LIN Division of Psychiatry
- 吳建昌 Division of Psychiatry
- 陳宜明 Division of Psychiatry
- Chen-Chung Liu Division of Psychiatry
- CHIH-MIN LIU Division of Psychiatry
- 吳其炘 Division of Psychiatry
- 徐勝駿 Division of Psychiatry
- YI-LING CHIEN Division of Psychiatry
- 廖士程 Division of Psychiatry
- 王宗揚 Division of Psychiatry
- 謝明憲 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳苡芃 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HSIN-CHIEN LEE Division of Psychiatry
- Kuo-Hsuan Chung Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- T.P. SU Division of Psychiatry
- W. C. LIN Division of Psychiatry
- Ya-Mei Bai Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
622 participants
